Efficacy of curcumin plus piperine co‐supplementation in moderate‐to‐high hepatic steatosis: A double‐blind, randomized, placebo‐controlled clinical trial
Phytotherapy Research · 2023-06 · 37 (6) · 2217-2229
DOI: 10.1002/ptr.7764 ↗At a glance
Randomisierte kontrollierte Studie in Phytotherapy Research, published online on 2023-02-17. Written by Shima Sharifi and 7 co-authors. Institution: Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medica…. Major MEDLINE topics: Curcumin, Non-alcoholic Fatty Liver Disease. Cited 42 times so far (Crossref); 69 references. Funded by: National Institute for Medical Research Development.
Abstract (original language)
Non‐alcoholic Fatty Liver Disease (NAFLD) is a global health problem that can progress to steatohepatitis and cirrhosis. The aim of this study was to determine the effect of curcumin + piperine on cardiometabolic risk factors, as well as hepatic steatosis and fibrosis in NAFLD patients with moderate‐to‐high hepatic steatosis. Patients diagnosed with moderate‐to‐high NAFLD by liver sonography were randomized to either curcumin + piperine (500 mg/day curcumin plus 5 mg/day piperine) for 12 weeks ( n = 30) or placebo groups ( n = 30). Liver fibroscan, anthropometric measurements, dietary intake, physical activity, blood pressure, lipid profile, high‐sensitivity C‐reactive protein, fasting blood glucose (FBG), and liver enzymes were assessed at baseline and after 12 weeks of follow‐up. Intention‐to‐treat analysis was undertaken. Curcumin + piperine decreased waist circumference ( p = 0.026), systolic blood pressure ( p = 0.001), total cholesterol ( p = 0.004), low‐density lipoprotein‐cholesterol ( p = 0.006), FBG ( p = 0.002), alanine transaminase ( p = 0.007) and aspartate transaminase ( p = 0.012) compared with placebo. However, fibroscan measurement did not differ between curcumin + piperine and placebo groups ( p > 0.05). Fibroscan measurement as a marker of NAFLD improvement did not differ after 12 weeks of curcumin + piperine; however, curcumin + piperine may be considered as an adjunct therapy to improve anthropometric measures, blood pressure, lipid profile, blood glucose, and liver function in NAFLD patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
- Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- School of Postgraduate Studies and Research, RCSI Medical University of Bahrain, Busaiteen, Bahrain.
- Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID profiles: Mohammad Bagherniya, Tannaz Jamialahmadi, Amirhossein Sahebkar, Gholamreza Askari
Funding
- National Institute for Medical Research Development
Cite
APA
Sharifi, S., Bagherniya, M., Khoram, Z., Ebrahimi Varzaneh, A., Atkin, S. L., Jamialahmadi, T., Sahebkar, A., & Askari, G. (2023). Efficacy of curcumin plus piperine co‐supplementation in moderate‐to‐high hepatic steatosis: A double‐blind, randomized, placebo‐controlled clinical trial. Phytotherapy Research, 37(6), 2217-2229. https://doi.org/10.1002/ptr.7764
Vancouver
Sharifi S, Bagherniya M, Khoram Z, Ebrahimi Varzaneh A, Atkin SL, Jamialahmadi T, et al. Efficacy of curcumin plus piperine co‐supplementation in moderate‐to‐high hepatic steatosis: A double‐blind, randomized, placebo‐controlled clinical trial. Phytotherapy Research. 2023;37(6):2217-2229. doi:10.1002/ptr.7764
BibTeX
@article{Sharifi2023,
author = {Sharifi, Shima and Bagherniya, Mohammad and Khoram, Ziba and Ebrahimi Varzaneh, Amrollah and Atkin, Stephen L and Jamialahmadi, Tannaz and Sahebkar, Amirhossein and Askari, Gholamreza},
title = {Efficacy of curcumin plus piperine co‐supplementation in moderate‐to‐high hepatic steatosis: A double‐blind, randomized, placebo‐controlled clinical trial},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {6},
pages = {2217--2229},
doi = {10.1002/ptr.7764}
}
EUVIMED